S
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K100.8 KBSynvista Therapeutics, Inc.Dec 24, 1:37 PM ET·0001144204-08-071073
- 10-K/A550.3 KBSynvista Therapeutics, Inc.Apr 29, 4:39 PM ET·0001144204-08-024859
- 8-K84.5 KBSynvista Therapeutics, Inc.Jan 23, 5:22 PM ET·0001144204-08-003601
- 3/A18.4 KBSynvista Therapeutics, Inc.Jan 3, 4:32 PM ET·0001209191-08-001108
- SC 13D/A72.4 KBSynvista Therapeutics, Inc.Jan 3, 4:31 PM ET·0000950123-08-000052
- 36.4 KBSynvista Therapeutics, Inc.Oct 3, 4:04 PM ET·0001209191-07-056739
- 8-K48.1 KBSynvista Therapeutics, Inc.Oct 1, 3:52 PM ET·0001144204-07-052087
- 449.7 KBSynvista Therapeutics, Inc.Sep 17, 6:31 PM ET·0001209191-07-053793
- 446.2 KBSynvista Therapeutics, Inc.Sep 17, 6:21 PM ET·0001209191-07-053788
- 453.0 KBSynvista Therapeutics, Inc.Sep 17, 5:19 PM ET·0001209191-07-053761
Insiders
10- Atticus Capital LP10% Owner
- BARAKETT TIMOTHY R10% Owner
- Bedard John F.Director
- Berkowitz NoahDirector, President & CEO, 10% Owner
- BRANSOME EDWIN D JRDirector
- BRESLOW MARILYN GDirector
- Mendel Carl MVP & Chief Medical Officer
- MOORE THOMAS ADirector
- NAIMARK GEORGE M PHDDirector
- ODELL ELIZABETH AVice President, Finance
Tickers
No tickers on record
Addresses
business
221 WEST GRAND AVENUE
MONTVALE,, NJ, 07645
mailing
221 WEST GRAND AVENUE
MONTVALE,, NJ, 07645
Former Names
- ALTEON INC /DE2007-07-31